Tissue exposure does not explain non-response in ulcerative colitis patients with adequate serum vedolizumab concentrations

N Van den Berghe, B Verstockt, A Gils… - Journal of Crohn's …, 2021 - academic.oup.com
Abstract Background and Aims Some patients with ulcerative colitis [UC] do not respond to
vedolizumab treatment despite adequate drug exposure in serum. This study aimed to …
被引用次数：12 相关文章

Tissue Exposure does not Explain Non-Response in Ulcerative Colitis Patients with Adequate Serum Vedolizumab Concentrations.

N Van den Berghe, B Verstockt, A Gils… - Journal of Crohn's & …, 2021 - europepmc.org
Methods A paired serum sample and colonic mucosal biopsy was collected from 40 UC
patients [20 endoscopic responders, 20 non-responders] at week 14 of vedolizumab …

Tissue Exposure does not Explain Non-Response in Ulcerative Colitis Patients with Adequate Serum Vedolizumab Concentrations.

NV Berghe, B Verstockt, A Gils… - Journal of Crohn's …, 2021 - search.ebscohost.com
Abstract Background and Aims Some patients with ulcerative colitis [UC] do not respond to
vedolizumab treatment despite adequate drug exposure in serum. This study aimed to …

Tissue Exposure does not Explain Non-Response in Ulcerative Colitis Patients with Adequate Serum Vedolizumab Concentrations

N Van den Berghe, B Verstockt, A Gils… - Journal of Crohn's …, 2021 - academic.oup.com
Abstract Background and Aims Some patients with ulcerative colitis [UC] do not respond to
vedolizumab treatment despite adequate drug exposure in serum. This study aimed to …
[PDF] kuleuven.be

[PDF][PDF] Tissue exposure does not explain non-response in ulcerative colitis patients with adequate serum vedolizumab concentrations

N Van den Berghe, B Verstockt, A Gils, J Sabino… - 2020 - lirias.kuleuven.be
Background and aims: Some patients with ulcerative colitis (UC) do not respond to
vedolizumab treatment despite adequate drug exposure in serum. This study aimed to …

Tissue Exposure does not Explain Non-Response in Ulcerative Colitis Patients with Adequate Serum Vedolizumab Concentrations

N Van den Berghe, B Verstockt… - Journal of Crohn's …, 2021 - pubmed.ncbi.nlm.nih.gov
Background and aims Some patients with ulcerative colitis [UC] do not respond to
vedolizumab treatment despite adequate drug exposure in serum. This study aimed to …